The price a stock trades at can drastically impact your overall returns. If you wait for a top growth stock to come down to a ...

Eli Lilly shares first human trial results for LOXO-435, a selective FGFR3 inhibitor for bladder cancer, showing 41% response ...

There are four managers listed on the fund: Jeremy Brown, Ferian Juwono, Agnes Zau, Christopher Bliss. The team is well equipped, with an average of 10 years of portfolio management experience.